1. Home
  2. BBAR vs PTGX Comparison

BBAR vs PTGX Comparison

Compare BBAR & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBAR
  • PTGX
  • Stock Information
  • Founded
  • BBAR 1886
  • PTGX 2006
  • Country
  • BBAR Argentina
  • PTGX United States
  • Employees
  • BBAR N/A
  • PTGX N/A
  • Industry
  • BBAR Commercial Banks
  • PTGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BBAR Finance
  • PTGX Health Care
  • Exchange
  • BBAR Nasdaq
  • PTGX Nasdaq
  • Market Cap
  • BBAR 2.7B
  • PTGX 2.8B
  • IPO Year
  • BBAR N/A
  • PTGX 2016
  • Fundamental
  • Price
  • BBAR $13.57
  • PTGX $47.91
  • Analyst Decision
  • BBAR
  • PTGX Strong Buy
  • Analyst Count
  • BBAR 0
  • PTGX 7
  • Target Price
  • BBAR N/A
  • PTGX $52.83
  • AVG Volume (30 Days)
  • BBAR 597.6K
  • PTGX 450.1K
  • Earning Date
  • BBAR 11-19-2024
  • PTGX 11-08-2024
  • Dividend Yield
  • BBAR 12.13%
  • PTGX N/A
  • EPS Growth
  • BBAR N/A
  • PTGX N/A
  • EPS
  • BBAR 0.24
  • PTGX 2.75
  • Revenue
  • BBAR $2,631,545,762.00
  • PTGX $319,120,000.00
  • Revenue This Year
  • BBAR N/A
  • PTGX $400.33
  • Revenue Next Year
  • BBAR N/A
  • PTGX N/A
  • P/E Ratio
  • BBAR $22.13
  • PTGX $17.54
  • Revenue Growth
  • BBAR N/A
  • PTGX 125.73
  • 52 Week Low
  • BBAR $3.86
  • PTGX $13.76
  • 52 Week High
  • BBAR $14.45
  • PTGX $48.89
  • Technical
  • Relative Strength Index (RSI)
  • BBAR 66.75
  • PTGX 60.40
  • Support Level
  • BBAR $11.22
  • PTGX $45.33
  • Resistance Level
  • BBAR $14.45
  • PTGX $48.89
  • Average True Range (ATR)
  • BBAR 0.63
  • PTGX 1.28
  • MACD
  • BBAR 0.21
  • PTGX 0.11
  • Stochastic Oscillator
  • BBAR 70.11
  • PTGX 77.11

About BBAR Banco BBVA Argentina S.A. ADS

Banco BBVA Argentina SA is a banking services provider in Argentina. It provides financial assistance to large corporations, small and medium-sized companies, as well as individuals. It bank provides services through retail, corporate, investment banking, and Small and medium-sized companies divisions. Through the retail banking segment, it provides banking products and services to individuals, corporate banking deals with services to corporates, and the small and medium-sized companies segment focused on foreign trade, agricultural business, and digital products.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

Share on Social Networks: